NEW YORK, June 4 – Illumina said Monday that R. Scott Greer, chairman and CEO of Abgenix, had been elected to its board of directors.
"We are honored that Scott has agreed to join our board. He brings a solid record of leadership and accomplishment in the life sciences industry and his insight and experience will be a tremendous asset to the company," said Jay Flatley, Illumina’s CEO, said in a statement.
Greer has been CEO of Abgenix since 1996. Prior to that he held senior positions with Cell Genesys. He has a bachelors in economics from Whitman College and an M.B.A. from Harvard University.
Greer will replace Charles Hartman, who did not stand for re-election.
Illumina of San Diego develops BeadArray technology to study genetic variation and function.